The increased release of TNFα and IL-1β in PBMCs from COPD patients support that systemic inflammation is relevant in COPD, even more since all recruited COPD patients were under inhaled steroid treatment. This evidence concerns the gene IL1B and chronic obstructive pulmonary disease.